Vitamin B-6 deficiency is common and associated with poor long-term outcome in renal transplant recipients

Isidor Minović*, Ineke J. Riphagen, Else van den Berg, Jenny E. Kootstra-Ros, Martijn van Faassen, Antonio W. Gomes Neto, Johanna M. Geleijnse, Reinold O.B. Gans, Manfred Eggersdorfer, Gerjan J. Navis, Ido P. Kema, Stephan L.J. Bakker

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)

Abstract

Background: Previous studies have reported low circulating concentrations of pyridoxal-5-phospate (PLP) in renal transplant recipients (RTRs). It is unknown whether this is because of low intake or altered handling, and it is also unknown whether variation in circulating concentrations of PLP influences long-term outcome. Objective: We compared Vitamin B-6 intake and circulating PLP concentrations of RTRs with those of healthy controls and investigated long-term clinical implications of Vitamin B-6 deficiency in stable outpatient RTRs. Design: In a longitudinal cohort of 687 stable RTRs (57% male; mean ± SD age: 53 ± 13 y) with a median (IQR) follow-up of 5.3 y (4.8-6.1 y) and 357 healthy controls (47% male; age 54 ± 11 y), baseline Vitamin B-6 was measured as plasma PLP by highperformance liquid chromatography (HPLC). Vitamin B-6 deficiency was defined as PLP<20 nmol/L, and insufficiency as PLP 20-30 nmol/L. Dietary intake was assessed by validated foodfrequency questionnaires. Results: At inclusion [5.3 y (1.8-12.1 y) after transplantation], the mean Vitamin B-6 intakes in RTRs and healthy controls were 1.77 ± 0.49 and 1.85 ± 0.56 mg/d, respectively (P = 0.23). In these groups, the median plasma PLP concentrations were 29 nmol/L (17-50 nmol/L) and 41 nmol/L (29-60 nmol/L), respectively (P<0.001). Accordingly, deficiency was present in 30% of RTRs compared with 11% of healthy controls. PLP concentrations were inversely associated with glucose homeostasis variables and inflammation variables (all P<0.01). During follow-up, 149 (21%) RTRs died and 82 (12%) developed graft failure. In RTRs, Vitamin B-6 deficiency was associated with considerably higher mortality risk (HR 2.14; 95% CI: 1.48, 3.08) than a sufficient Vitamin B-6 status, independent of potential confounders. No associations were observed for graft failure (P = 0.18). Conclusions: Vitamin B-6 deficiency is common in RTRs and does not seem to be a consequence of inadequate intake. In addition, this deficient state is clinically relevant and independently associated with an increased risk of mortality in RTRs. The cohort on which the study was based [TransplantLines Food and Nutrition Biobank and Cohort Study (TxL-FN)] was registered at clinicaltrials.gov as NCT02811835. Am J Clin Nutr 2017;105:1344-50.

Original languageEnglish
Pages (from-to)1344-1350
JournalAmerican Journal of Clinical Nutrition
Volume105
Issue number6
DOIs
Publication statusPublished - 2017

Keywords

  • Diabetes mellitus
  • Inflammation
  • Kidney transplantation
  • Long-term graft failure
  • Long-term mortality
  • Pyridoxal 5≤-phosphate
  • Vitamin B-6 deficiency

Fingerprint Dive into the research topics of 'Vitamin B-6 deficiency is common and associated with poor long-term outcome in renal transplant recipients'. Together they form a unique fingerprint.

Cite this